Volatility has been the theme of 2026. The VIX touched 31.05 in late March before settling back to a current reading of 15.86, and the 10-year Treasury yield sits at 4.70%, near the top of its 12-month range.

Volatility has been the theme of 2026. The VIX touched 31.05 in late March before settling back to a current reading of 15.86, and the 10-year Treasury yield sits at 4.70%, near the top of its 12-month range.
Good morning, CFOs. Wayfair CFO Kate Gulliver on signs of a rebound in the U.S.; Elon Musk outlined ambitious targets for SpaceX following its first-ever earnings report; Procter & Gamble will buy supplement company Thorne; plus, Portillo's hires new CFO.
The Dow Dogs remain broadly overvalued, with none meeting the ideal 'fair price' threshold where dividends from $1K invested exceed share price. Analyst forecasts suggest the top ten Dow Dogs could deliver 18.3% to 54.76% net gains by August 2027, with an average projected return of 29.64%. Only 21 of 30 Dow stocks are considered 'safer' for dividends, supported by free cash flow; Nike is closest to 'ideal' but still has a negative safety margin.
L Catterton's Deep Category Conviction and Brand Vision Allowed for Accelerated Growth and Fortified Thorne's Position as the Premier Trusted Brand in Science-Backed Wellness GREENWICH, Conn., Aug. 4, 2026 /PRNewswire/ -- L Catterton, the largest global consumer-focused investment firm, today announced that it has signed a definitive agreement to sell Thorne, a leader in science-backed health and wellness solutions, to The Procter & Gamble Company (NYSE: PG) for $3.8 billion in cash.
Acquisition positions Thorne to continue advancing its mission while building on its legacy of science, quality, innovation, and trust SUMMERVILLE, S.C., Aug. 4, 2026 /PRNewswire/ -- Thorne, the leader in science-backed health and wellness solutions, today announced that it has entered into a definitive agreement to be acquired by The Procter & Gamble Company (NYSE: PG).
The consumer-goods giant will buy Thorne to bolster its presence in the beauty and wellness industry.
Tide maker Procter & Gamble will announce the acquisition of supplements maker Thorne on Tuesday, P&G CEO Shailesh Jejurikar told CNBC in an interview.
Procter & Gamble is buying supplement brand Thorne. P&G CEO Shailesh Jejurikar said the acquisition is play to grow the company's health business on CNBC's "Squawk on the Street.
Charlie Munger once extolled the virtues of investing in a concentrated handful of high-conviction investment ideas. I share the 3 dividend investments that I would pick for the next decade. I detail the risk-reward profile of each.
The Magnificent Seven is a nickname for a small group of high-performing stocks. It is important to remember the old Wall Street saying that trees don't grow to the sky.